Lysodren – Mitotane

Lysodren is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenal cortical carcinoma.

The recommended initial dose of Lysodren is 2 g to 6 g orally, in three or four divided doses per day. Increase doses incrementally to achieve a blood concentration of 14 to 20 mg/L, or as tolerated.

Lysodren is a cytotoxic drug. Follow applicable special handling and disposal procedures.